KIRhub 2.0
Sign inResearch Use Only

MELK

Sign in to save this workspace

UniProt Q14680 · PDB · AlphaFold · Substrate: ZIPtide · Clone: aa 1-340medium-confidence target

Top inhibitors

#DrugInhibitionResidualKISSGini
1Nintedanib99.4%0.6%90.230.608
2Midostaurin94.9%5.1%78.640.500
3Sunitinib87.8%12.2%91.730.524
4Defactinib81.4%18.6%92.680.450
5Neratinib78.2%21.8%93.180.597
6Alectinib70.3%29.7%95.490.651
7Selpercatinib60.4%39.6%96.720.635
8Brigatinib51.4%48.6%82.960.513
9Tepotinib50.4%49.6%99.750.727
10Palbociclib46.6%53.4%98.750.673
11Gilteritinib44.6%55.4%88.970.506
12Dabrafenib42.7%57.3%94.740.633
13Fedratinib42.6%57.4%96.210.576
14Ponatinib40.0%60.0%78.230.534
15Gefitinib31.0%69.0%99.250.650
16Dacomitinib30.2%69.8%97.990.664
17Avapritinib28.3%71.7%97.730.644
18Ruxolitinib28.2%71.8%98.250.592
19Entrectinib23.5%76.5%93.690.671
20Pacritinib20.6%79.4%88.640.452

Paralog block

No paralog group registered for this kinase.

EMT expression

  • Mesenchymal log2(TPM+1): 5.20
  • Epithelial log2(TPM+1): 4.89
  • Fold change: 0.31
  • Status: No significant change

High-confidence drugs

  1. Nintedanib — inh 99.4% · KISS 36.77
  2. Midostaurin — inh 94.9% · KISS 24.80
  3. Sunitinib — inh 87.8% · KISS 21.45

Selectivity landscape vs inhibition on MELK

Each point is one of the 92 approved drugs; color = inhibition % on MELK.

Mutation lollipop

Cancer-associated mutations plotted by residue position. Marker size + color scale with the number of distinct cancer reports.

Variants (1)

Mutation × cancer associations

MutationCancerOrganSource
T460Mcarcinoma_ovaryOvaryref
T460Mcarcinoma_kidneyKidneyref
T460MCOREADLarge Intestineref

3D structure

Embedded NGL viewer pulls a representative PDB entry (or AlphaFold model if no experimental structure is registered). Heavy bundle — loaded only on demand.

Annotations

Sign in to read and post annotations.

Loading…